Mental health
US: Report reveals striking gender device in prescription medication spending

Women shoulder a significantly greater out-of-pocket cost burden than men when it comes to prescription medication spending, according to a US report.
The data shows that in 2024, women spent $8.8 billion – or 30 per cent – more than men on out-of-pocket prescription costs.
Combined with the common responsibilities of managing a career, family planning, and caregiving, women are left frustrated with the financial pressure required to maintain their health.
Though the “pink tax” is often thought about as higher prices on consumer goods, the research suggests that it also manifests itself in the hidden costs of healthcare.
Higher healthcare utilisation, higher rates of chronic conditions, and spending on female-specific conditions like women’s fertility and menopause contribute to this imbalance.
Women are filling more prescriptions than men, but forgoing treatment isn’t more cost effective in the long run, either.
If left untreated, many of the conditions women are proactively managing can be debilitating, interrupting their lives and work, and necessitating more serious and expensive medical interventions down the line.
Tori Marsh, MPH is Director of Research at GoodRx which authored the report.
Marsh said: “Though we typically think of the ‘pink tax’ as an upcharge on goods and services, these latest findings illustrate how the spending gap between men and women transcends grocery store shelves, with women paying a premium just to maintain their health.
“This gender inequality leaves women with a greater financial burden, potentially requiring women to choose between their own health and other recurring expenses.
This can lead to more serious health issues and create extra strain–not just on individuals–but on the healthcare system as a whole.”
The report found that women spent 30 per cent more out-of-pocket than men last year, a trend that has remained consistent over recent years.
Menopause treatments, for example, cost an average of $16.95 per prescription.
Conditions that demand specialised treatments, like endometriosis and morning sickness, require an even more substantial spend ($29.38 and $37.87 per prescription, respectively).
Women ages 18 to 44 spend up to 64 per cent more out-of-pocket on medications than men of the same age group. As they age, the gap gets smaller.
Women ages 45 to 64 spent 35.3 64 per cent more than men in 2024, and women over 65 spent 16.5 64 per cent more.
According to the report, women also spend 113 64 per centmore out-of-pocket on depression medications and 103 64 per cent more on anxiety treatments than men.
These disparities are likely driven by both higher prescription fill rates and systemic factors, such as differences in how mental health conditions are diagnosed and treated between genders.
Mental health
Women over 40 seeking raves for mental health benefits
Fertility
Housing, work and fertility stop Britons having the families they want – research
Menopause
CBT shows promise for menopause insomnia and hot flashes

Cognitive behavioural therapy (CBT) may offer short-term relief for menopause insomnia and night-time hot flushes, a pilot study suggests.
CBT is a structured, short-term talking treatment that helps people change thoughts and behaviours that can worsen sleep problems.
Researchers found the intervention was linked to meaningful short-term improvements in insomnia severity, hot flush interference, sleep self-efficacy, or confidence around sleep, and depressive symptoms.
The Menopause Society said insomnia affects an estimated 20 to 60 per cent of perimenopausal and postmenopausal women in the US.
Ongoing research is focusing on effective treatments because insomnia can have serious physical and psychological effects.
Dr Monica Christmas, associate medical director for The Menopause Society, said: “Nocturnal hot flushes (night sweats) and sleep disruption can have a significant effect on the quality of life with many women claiming extreme impairment due to symptoms that often start in early perimenopause and last 10 or more years.”
“Sleep disturbances can persist even in those using pharmacological therapy to manage hot flushes.
“The study’s findings highlight the utility of cognitive-behavioural therapy as a standalone treatment for insomnia and hot flushes, offering women an alternative or adjunct to pharmacological treatments.”
Insomnia is defined as disturbed sleep associated with distress or impaired daily functioning and is one of the most common complaints in perimenopause and postmenopause.
It can reduce quality of life and is linked to higher healthcare use and costs, disability, depression and cardiovascular disease.
Hot flushes occur in 60 to 80 per cent of women during the menopause transition and can persist for four to five years on average.
Night-time hot flushes are linked to sleep disruption, and women may respond by napping or spending longer in bed, which can help keep insomnia going.
Previous studies have shown that cognitive behavioural therapy is an effective treatment for insomnia and may also help women cope with hot flushes and other menopause symptoms.
However, few trials have looked at both insomnia and hot flushes together.
Insomnia during and after the menopause transition is complex and can have many causes, including ageing, hormone fluctuation, hot flushes, other sleep disorders, psychiatric and medical conditions and psychosocial stressors.
Because women with acute and sustained insomnia can experience greater negative health effects, effective treatment is important.
The pilot study concluded that CBT was feasible and may be a promising approach for menopause-related insomnia and nocturnal hot flushes, although the benefits appeared to lessen after three months.
Fertility3 weeks agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
News3 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Diagnosis3 weeks agoNew meta-analysis further supports low re-excisions and high placement accuracy with the Magseed marker
Pregnancy3 weeks agoNIPT or NT scan? Why the 2026 evidence supports doing Both
Mental health4 weeks agoLifting weights shows mental health and cognitive benefits in older women, study finds
News4 weeks agoResistance training has preventative effects in menopause, study finds
Wellness2 weeks agoWomen’s HealthX unveils Northwell Health, Corewell Health, Biogen & more to headline Chronic Disease stage
Insight3 weeks agoWhy the UK’s fertility rate keeps falling – and what it means if you’re trying now














